Clinical Trial Update: Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy and safety of Polidocanol Foam 3% for second-degree hemorrhoidal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Second-degree Hemorrhoids

Drugs mentioned

• Polidocanol Foam 3% (polidocanol)

Snippet

Sponsor: Societa Italiana di Chirurgia ColoRettale | Conditions: Second-degree Hemorrhoids | Phase 2 | Status: COMPLETED